Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses Meeting Abstract
| Authors: | Abida, W.; Campbell, D.; Patnaik, A.; Sautois, B.; Shapiro, J.; Vogelzang, N. J.; Bryce, A. H.; McDermott, R.; Ricci, F.; Rowe, J.; Zhang, J.; Simmons, A. D.; Despain, D.; Dowson, M.; Golsorkhi, T.; Chowdhury, S. |
| Abstract Title: | Preliminary results from the TRITON2 study of rucaparib in patients (pts) with DNA damage repair (DDR)-deficient metastatic castration-resistant prostate cancer (mCRPC): Updated analyses |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz248.003 |
| Language: | English |
| ACCESSION: | WOS:000491295502273 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz248.003 |
| Notes: | Meeting Abstract: 846PD -- Appears on pages v327-v328 of the abstract book -- Source: Wos |
